Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Cited by (1,026)

Items 1,001–1,026 of 1,026

1. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
   Chiou‐Feng Lin, Chih-Ming Lin, Kang-Yun Lee, Kuan-Yuan Chen, Po‐Hao Feng, Chia‐Ling Chen, Hsiao‐Chi Chuang, Chia-Ling Chen, Yu‐Chih Wang, Po‐Chun Tseng et al. · 2017 · Journal of Biomedical Science
2. Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
   Vasiliki Pelekanou, Daniel Carvajal‐Hausdorf, Mehmet Altan, Brad E Wasserman, Cristobal Carvajal-Hausdorf, Hallie Wimberly, Jason Robert Brown, Donald R. Lannin, Lajos Pusztai, David L. Rimm · 2017 · Breast Cancer Research
3. Follicular helper-T cells restore CD8 + -dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
   Julie Niogret, Hélène Berger, Cédric Rébé, Romain Mary, Elise Ballot, Caroline Truntzer, Marion Thibaudin, Valentin Dérangère, Christophe Hibos, Léa Hampe et al. · 2021 · Journal for ImmunoTherapy of Cancer
4. Mechanisms of immune checkpoint inhibitor-mediated liver injury
   Shojaie, Layla, Ali, Myra, Iorga, Andrea, Dara, Lily · 2021 · Acta Pharmaceutica Sinica B
5. Exosomal PD‐L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
   Zhou, Kaijian, Guo, Shu, Li, Fei, Sun, Qiang, Liang, Guoxin · 2020 · Frontiers in Cell and Developmental Biology
6. GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
   Park, Jeong A., Cheung, Nai-Kong V. · 2020 · Journal of Hematology & Oncology
7. Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
   Saito, Hiroaki, Kuroda, Hirohiko, Matsunaga, Tomoyuki, Osaki, Tomohiro, Ikeguchi, Masahide · 2013 · Journal of Surgical Oncology
8. Immune Microenvironment Differences Between Squamous and Non-squamous Non–small-cell Lung Cancer and Their Influence on the Prognosis
   Meng, Xiangjiao, Gao, Yongsheng, Yang, Lian, Jing, Haiyan, Teng, Feifei, Huang, Zhaoqin, Xing, Ligang · 2019 · Clinical Lung Cancer
9. Human Hepatic Stellate Cells Inhibit T-Cell Response Through B7-H1 Pathway
   Charles, Ronald, Chou, Hong-Shiue, Wang, Lianfu, Fung, John J., Lu, Lina, Qian, Shiguang · 2013 · Transplantation
10. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy
    Wang, Yiming, Ma, Rena, Liu, Fang, Lee, Seul A., Zhang, Li · 2018 · Frontiers in Immunology
11. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon‐γ signaling†
    Yang, Horng‐Ren, Chou, Hong‐Shuie, Gu, Xiaodong, Wang, Lianfu, Brown, Kathleen E., Fung, John J., Lu, Lina, Qian, Shiguang · 2009 · Hepatology
12. The effects of age and systemic metabolism on anti-tumor T cell responses
    Drijvers, Jefte M, Sharpe, Arlene H, Haigis, Marcia C · 2020 · eLife
13. Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Tremblay-LeMay, Rosemarie, Rastgoo, Nasrin, Chang, Hong · 2018 · Journal of Hematology & Oncology
14. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue
    Aguirre, Luis E., Guzman, Maria E., Lopes, Gilberto, Hurley, Judith · 2019 · The Oncologist
15. Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors
    Lim, Ee Lyn, Cugliandolo, Fiorella M., Rosner, Dalya R., Gyori, David, Roychoudhuri, Rahul, Okkenhaug, Klaus · 2018 · JCI Insight
16. Distinct Role for CD8 T Cells toward Cutaneous Tumors and Visceral Metastases
    Lengagne, Renée, Graff-Dubois, Stéphanie, Garcette, Marylène, Renia, Laurent, Kato, Masashi, Guillet, Jean-Gérard, Engelhard, Victor H, Avril, Marie-Françoise, Abastado, Jean-Pierre, Prévost-Blondel, Armelle · 2008 · The Journal of Immunology
17. Considerations for successful cancer immunotherapy in aged hosts
    Hurez, V, Padrón, Á S, Svatek, R S, Curiel, T J · 2016 · Clinical and Experimental Immunology
18. Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Paderi, Agnese, Giorgione, Roberta, Giommoni, Elisa, Mela, Marinella, Rossi, Virginia, Doni, Laura, Minervini, Andrea, Carini, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo · 2021 · Cancers
19. Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
    Berezhnoy, Alexey, Sumrow, Bradley J., Stahl, Kurt, Shah, Kalpana, Liu, Daorong, Li, Jonathan, Hao, Su-Shin, De Costa, Anushka, Kaul, Sanjeev, Bendell, Johanna et al. · 2020 · Cell Reports Medicine
20. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
    Jo, Wonyoung, Won, Taejoon, Daoud, Abdel, Čiháková, Daniela · 2024 · Frontiers in Immunology
21. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: a systematic review
    Ghanizada, Mustafa, Jakobsen, Kathrine Kronberg, Grønhøj, Christian, von Buchwald, Christian · 2019 · Oral Oncology
22. PD‐L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation
    Rodić, Nemanja, Anders, Robert A., Eshleman, James R., Lin, Ming-Tseh, Xu, Haiying, Kim, Jung H., Beierl, Katie, Chen, Shuming, Luber, Brandon S., Wang, Hao et al. · 2015 · Cancer Immunology Research
23. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells
    Ge, Wei, Ma, Xiaotong, Li, Xin, Wang, Yafei, Li, Changhong, Meng, Hengxing, Liu, Xiaofan, Yu, Zhen, You, Shengguo, Qiu, Lugui · 2009 · Leukemia Research
24. Leveraging microenvironmental synthetic lethalities to treat cancer
    Metcalf, Kevin J., Alazzeh, Alaa, Werb, Zena, Weaver, Valerie M. · 2021 · Journal of Clinical Investigation
25. Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma
    Liu, Z, Mi, F, Han, M, Tian, M, Deng, L, Meng, N, Luo, J, Fu, R · 2021 · Clinical and Experimental Immunology
26. Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
    Wang, Yungang, Deng, Shouyan, Xu, Jie · 2020 · Cancer Biology and Medicine